Full Fed. Circ. Won't Review Inventorship Row Over Cancer IP

Law360 (October 16, 2020, 6:13 PM EDT) -- The full Federal Circuit Friday rejected a bid from Bristol-Meyers and others for review of a panel decision that two American scientists from the Dana-Farber Cancer Institute should be named as co-inventors on six patents involved in Nobel Prize-winning cancer research.

The full court denied the en banc petition in a two-page order, dealing Ono Pharmaceutical Co. Ltd., Bristol-Meyers Squibb Company and Tasuku Honjo a blow in their effort to undo the panel's July decision.

They had argued that the panel created an erroneous new rule on inventorship by affirming a district court ruling that the scientists — Gordon Freeman and...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!